Skip to main content
Erschienen in: Current Diabetes Reports 8/2014

01.08.2014 | Microvascular Complications—Retinopathy (JK Sun, Section Editor)

Genetics of Diabetic Retinopathy

verfasst von: Heeyoon Cho, Lucia Sobrin

Erschienen in: Current Diabetes Reports | Ausgabe 8/2014

Einloggen, um Zugang zu erhalten

Abstract

Diabetic retinopathy (DR) is a polygenic disorder. Twin studies and familial aggregation studies have documented clear familial clustering. Heritability has been estimated to be as high as 27 % for any DR and 52 % for proliferative diabetic retinopathy (PDR), an advanced form of the disease. Linkage analyses, candidate gene association studies and genome-wide association studies (GWAS) performed to date have not identified any widely reproducible risk loci for DR. Combined analysis of the data from multiple GWAS is emerging as an important next step to explain the unaccounted heritability. Key factors to future discovery of the genetic underpinnings of DR are precise DR ascertainment, a focus on the more heritable disease forms such as PDR, stringent selection of control participants with regards to duration of diabetes, and methods that allow combination of existing datasets from different ethnicities to achieve sufficient sample sizes to detect variants with modest effect sizes.
Literatur
1.
Zurück zum Zitat National Institute of Diabetes and Digestive and Kidney Diseases. National diabetes statistics fact sheet: general information and national estimates on diabetes in the United States, 2000. Bethesda, MD: U.S. Department of Health and Human Services, National Institute of Health, Publication No. 02-3892. National Institute of Diabetes and Digestive and Kidney Diseases. National diabetes statistics fact sheet: general information and national estimates on diabetes in the United States, 2000. Bethesda, MD: U.S. Department of Health and Human Services, National Institute of Health, Publication No. 02-3892.
2.
3.
Zurück zum Zitat Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology. 1998;105:1801–15.PubMedCrossRef Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology. 1998;105:1801–15.PubMedCrossRef
4.
Zurück zum Zitat Klein R, Klein BE, Moss SE, Cruickshanks KJ. Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med. 1994;154:2169–78.PubMedCrossRef Klein R, Klein BE, Moss SE, Cruickshanks KJ. Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med. 1994;154:2169–78.PubMedCrossRef
5.
Zurück zum Zitat Klein R, Klein BE, Moss SE, Linton KL. The Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus. Ophthalmology. 1992;99:58–62.PubMedCrossRef Klein R, Klein BE, Moss SE, Linton KL. The Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus. Ophthalmology. 1992;99:58–62.PubMedCrossRef
6.•
Zurück zum Zitat Kuo JZ, Wong TY, Rotter JI. Challenges in elucidating the genetics of diabetic retinopathy. JAMA Ophthalmol. 2014;132:96–107. Comprehensive review article of the challenges facing the field of diabetic retinopathy genetics.PubMedCentralPubMedCrossRef Kuo JZ, Wong TY, Rotter JI. Challenges in elucidating the genetics of diabetic retinopathy. JAMA Ophthalmol. 2014;132:96–107. Comprehensive review article of the challenges facing the field of diabetic retinopathy genetics.PubMedCentralPubMedCrossRef
7.••
Zurück zum Zitat Abhary S, Hewitt AW, Burdon KP, Craig JE. A systematic meta-analysis of genetic association studies for diabetic retinopathy. Diabetes. 2009;58:2137–47. Thorough meta-analysis of many of the candidate gene studies performed for diabetic retinopathy.PubMedCentralPubMedCrossRef Abhary S, Hewitt AW, Burdon KP, Craig JE. A systematic meta-analysis of genetic association studies for diabetic retinopathy. Diabetes. 2009;58:2137–47. Thorough meta-analysis of many of the candidate gene studies performed for diabetic retinopathy.PubMedCentralPubMedCrossRef
8.
Zurück zum Zitat Omar AF, Silva PS, Sun JK. Genetics of diabetic retinopathy. Semin Ophthalmol. 2013;28:337–46.PubMedCrossRef Omar AF, Silva PS, Sun JK. Genetics of diabetic retinopathy. Semin Ophthalmol. 2013;28:337–46.PubMedCrossRef
10.
Zurück zum Zitat Schwartz SG, Brantley Jr MA, Flynn Jr HW. Genetics and diabetic retinopathy. Curr Diabetes Rev. 2013;9:86–92.PubMedCrossRef Schwartz SG, Brantley Jr MA, Flynn Jr HW. Genetics and diabetic retinopathy. Curr Diabetes Rev. 2013;9:86–92.PubMedCrossRef
11.
12.
Zurück zum Zitat Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes. Control and Complications Trial Research Group. Diabetes. 1997;46:1829–39. Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes. Control and Complications Trial Research Group. Diabetes. 1997;46:1829–39.
14.
Zurück zum Zitat Looker HC, Nelson RG, Chew E, et al. Genome-wide linkage analyses to identify Loci for diabetic retinopathy. Diabetes. 2007;56:1160–6.PubMedCrossRef Looker HC, Nelson RG, Chew E, et al. Genome-wide linkage analyses to identify Loci for diabetic retinopathy. Diabetes. 2007;56:1160–6.PubMedCrossRef
15.
Zurück zum Zitat Rema M, Saravanan G, Deepa R, Mohan V. Familial clustering of diabetic retinopathy in South Indian Type 2 diabetic patients. Diabetes Med. 2002;19:910–6.CrossRef Rema M, Saravanan G, Deepa R, Mohan V. Familial clustering of diabetic retinopathy in South Indian Type 2 diabetic patients. Diabetes Med. 2002;19:910–6.CrossRef
16.
Zurück zum Zitat Zhang X, Gao Y, Zhou Z, et al. Familial clustering of diabetic retinopathy in Chongqing, China, type 2 diabetic patients. Eur J Ophthalmol. 2010;20:911–8.PubMed Zhang X, Gao Y, Zhou Z, et al. Familial clustering of diabetic retinopathy in Chongqing, China, type 2 diabetic patients. Eur J Ophthalmol. 2010;20:911–8.PubMed
17.
Zurück zum Zitat Hallman DM, Huber Jr JC, Gonzalez VH, et al. Familial aggregation of severity of diabetic retinopathy in Mexican Americans from Starr County. Texas Diabetes Care. 2005;28:1163–8.CrossRef Hallman DM, Huber Jr JC, Gonzalez VH, et al. Familial aggregation of severity of diabetic retinopathy in Mexican Americans from Starr County. Texas Diabetes Care. 2005;28:1163–8.CrossRef
18.
Zurück zum Zitat Arar NH, Freedman BI, Adler SG, et al. Heritability of the severity of diabetic retinopathy: the FIND-Eye study. Invest Ophthalmol Vis Sci. 2008;49:3839–45.PubMedCentralPubMedCrossRef Arar NH, Freedman BI, Adler SG, et al. Heritability of the severity of diabetic retinopathy: the FIND-Eye study. Invest Ophthalmol Vis Sci. 2008;49:3839–45.PubMedCentralPubMedCrossRef
19.
Zurück zum Zitat Imperatore G, Hanson RL, Pettitt DJ, et al. Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group Diabetes. 1998;47:821–30. Imperatore G, Hanson RL, Pettitt DJ, et al. Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group Diabetes. 1998;47:821–30.
20.
Zurück zum Zitat Hallman DM, Boerwinkle E, Gonzalez VH, et al. A genome-wide linkage scan for diabetic retinopathy susceptibility genes in Mexican Americans with type 2 diabetes from Starr County. Texas Diabetes. 2007;56:1167–73.CrossRef Hallman DM, Boerwinkle E, Gonzalez VH, et al. A genome-wide linkage scan for diabetic retinopathy susceptibility genes in Mexican Americans with type 2 diabetes from Starr County. Texas Diabetes. 2007;56:1167–73.CrossRef
21.
Zurück zum Zitat McCarthy MI, Abecasis GR, Cardon LR, et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet. 2008;9:356–69.PubMedCrossRef McCarthy MI, Abecasis GR, Cardon LR, et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet. 2008;9:356–69.PubMedCrossRef
22.
Zurück zum Zitat Tong Z, Yang Z, Patel S, et al. Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications. Proc Natl Acad Sci U S A. 2008;105:6998–7003.PubMedCentralPubMedCrossRef Tong Z, Yang Z, Patel S, et al. Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications. Proc Natl Acad Sci U S A. 2008;105:6998–7003.PubMedCentralPubMedCrossRef
23.
Zurück zum Zitat Abhary S, Burdon KP, Casson RJ, et al. Association between erythropoietin gene polymorphisms and diabetic retinopathy. Arch Ophthalmol. 2010;128:102–6.PubMedCrossRef Abhary S, Burdon KP, Casson RJ, et al. Association between erythropoietin gene polymorphisms and diabetic retinopathy. Arch Ophthalmol. 2010;128:102–6.PubMedCrossRef
24.•
Zurück zum Zitat Luo J, Zhao L, Chen AY, et al. TCF7L2 Variation and proliferative diabetic retinopathy. Diabetes. 2013;62:2613–7. Well-designed candidate gene study for diabetic retinopathy with independent replication.PubMedCentralPubMedCrossRef Luo J, Zhao L, Chen AY, et al. TCF7L2 Variation and proliferative diabetic retinopathy. Diabetes. 2013;62:2613–7. Well-designed candidate gene study for diabetic retinopathy with independent replication.PubMedCentralPubMedCrossRef
25.
Zurück zum Zitat Ciccacci C, Di Fusco D, Cacciotti L, et al. TCF7L2 gene polymorphisms and type 2 diabetes: association with diabetic retinopathy and cardiovascular autonomic neuropathy. Acta Diabetol. 2013;50:789–99. Ciccacci C, Di Fusco D, Cacciotti L, et al. TCF7L2 gene polymorphisms and type 2 diabetes: association with diabetic retinopathy and cardiovascular autonomic neuropathy. Acta Diabetol. 2013;50:789–99.
26.
Zurück zum Zitat Buraczynska M, Swatowski A, Markowska-Gosik D, Kuczmaszewska A, Ksiazek A. Transcription factor 7-like 2 (TCF7L2) gene polymorphism and complication/comorbidity profile in type 2 diabetes patients. Diabetes Res Clin Pract. 2011;93:390–5.PubMedCrossRef Buraczynska M, Swatowski A, Markowska-Gosik D, Kuczmaszewska A, Ksiazek A. Transcription factor 7-like 2 (TCF7L2) gene polymorphism and complication/comorbidity profile in type 2 diabetes patients. Diabetes Res Clin Pract. 2011;93:390–5.PubMedCrossRef
27.
Zurück zum Zitat Sobrin L, Green T, Sim X, et al. Candidate gene association study for diabetic retinopathy in persons with type 2 diabetes: the Candidate gene Association Resource (CARe). Invest Ophthalmol Vis Sci. 2011;52:7593–602.PubMedCentralPubMedCrossRef Sobrin L, Green T, Sim X, et al. Candidate gene association study for diabetic retinopathy in persons with type 2 diabetes: the Candidate gene Association Resource (CARe). Invest Ophthalmol Vis Sci. 2011;52:7593–602.PubMedCentralPubMedCrossRef
29.
Zurück zum Zitat Fritsche LG, Chen W, Schu M, et al. Seven new loci associated with age-related macular degeneration. Nat Genet. 2013;45:433–9. 9e1–2.PubMedCrossRef Fritsche LG, Chen W, Schu M, et al. Seven new loci associated with age-related macular degeneration. Nat Genet. 2013;45:433–9. 9e1–2.PubMedCrossRef
30.
Zurück zum Zitat Neale BM, Fagerness J, Reynolds R, et al. Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci U S A. 2010;107:7395–400.PubMedCentralPubMedCrossRef Neale BM, Fagerness J, Reynolds R, et al. Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci U S A. 2010;107:7395–400.PubMedCentralPubMedCrossRef
31.
Zurück zum Zitat Yu Y, Bhangale TR, Fagerness J, et al. Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration. Hum Mol Genet. 2011;20:3699–709. Yu Y, Bhangale TR, Fagerness J, et al. Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration. Hum Mol Genet. 2011;20:3699–709.
32.
Zurück zum Zitat Morris AP, Voight BF, Teslovich TM, et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012;44:981–90.PubMedCentralPubMedCrossRef Morris AP, Voight BF, Teslovich TM, et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012;44:981–90.PubMedCentralPubMedCrossRef
33.
Zurück zum Zitat Chen W, Stambolian D, Edwards AO, et al. Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A. 2010;107:7401–6.PubMedCentralPubMedCrossRef Chen W, Stambolian D, Edwards AO, et al. Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A. 2010;107:7401–6.PubMedCentralPubMedCrossRef
34.
Zurück zum Zitat Sandholm N, Salem RM, McKnight AJ, et al. New susceptibility loci associated with kidney disease in type 1 diabetes. PLoS Genet. 2012;8:e1002921.PubMedCentralPubMedCrossRef Sandholm N, Salem RM, McKnight AJ, et al. New susceptibility loci associated with kidney disease in type 1 diabetes. PLoS Genet. 2012;8:e1002921.PubMedCentralPubMedCrossRef
35.
Zurück zum Zitat Fu YP, Hallman DM, Gonzalez VH, et al. Identification of diabetic retinopathy genes through a genome-wide association study among Mexican-Americans from Starr County, Texas. J Ophthalmol. 2010;2010. doi:10.1155/2010/861291. Fu YP, Hallman DM, Gonzalez VH, et al. Identification of diabetic retinopathy genes through a genome-wide association study among Mexican-Americans from Starr County, Texas. J Ophthalmol. 2010;2010. doi:10.​1155/​2010/​861291.
36.••
Zurück zum Zitat Grassi MA, Tikhomirov A, Ramalingam S, et al. Genome-wide meta-analysis for severe diabetic retinopathy. Hum Mol Genet. 2011;20:2472–81. Largest genome-wide association carried out to date for diabetic retinopathy.PubMedCentralPubMedCrossRef Grassi MA, Tikhomirov A, Ramalingam S, et al. Genome-wide meta-analysis for severe diabetic retinopathy. Hum Mol Genet. 2011;20:2472–81. Largest genome-wide association carried out to date for diabetic retinopathy.PubMedCentralPubMedCrossRef
37.
Zurück zum Zitat Grassi MA, Tikhomirov A, Ramalingam S, et al. Replication analysis for severe diabetic retinopathy. Invest Ophthalmol Vis Sci. 2012;53:2377–81.PubMedCentralPubMedCrossRef Grassi MA, Tikhomirov A, Ramalingam S, et al. Replication analysis for severe diabetic retinopathy. Invest Ophthalmol Vis Sci. 2012;53:2377–81.PubMedCentralPubMedCrossRef
38.
Zurück zum Zitat Huang YC, Lin JM, Lin HJ, et al. Genome-wide association study of diabetic retinopathy in a Taiwanese Population. Ophthalmology. 2011;118:642–8.PubMedCrossRef Huang YC, Lin JM, Lin HJ, et al. Genome-wide association study of diabetic retinopathy in a Taiwanese Population. Ophthalmology. 2011;118:642–8.PubMedCrossRef
39.••
Zurück zum Zitat Sheu WH, Kuo JZ, Lee IT, et al. Genome-wide association study in a Chinese population with diabetic retinopathy. Hum Mol Genet. 2013;22:3165–73. Genome-wide association study that accounted well for nongenetic risk factors (glycemic control and duration of diabetes).PubMedCrossRef Sheu WH, Kuo JZ, Lee IT, et al. Genome-wide association study in a Chinese population with diabetic retinopathy. Hum Mol Genet. 2013;22:3165–73. Genome-wide association study that accounted well for nongenetic risk factors (glycemic control and duration of diabetes).PubMedCrossRef
40.
Zurück zum Zitat Silva PS, Cavallerano JD, Sun JK, et al. Nonmydriatic ultrawide field retinal imaging compared with dilated standard 7-field 35-mm photography and retinal specialist examination for evaluation of diabetic retinopathy. Am J Ophthalmol. 2012;154:549–59.e2.PubMedCrossRef Silva PS, Cavallerano JD, Sun JK, et al. Nonmydriatic ultrawide field retinal imaging compared with dilated standard 7-field 35-mm photography and retinal specialist examination for evaluation of diabetic retinopathy. Am J Ophthalmol. 2012;154:549–59.e2.PubMedCrossRef
41.
Zurück zum Zitat Aiello LP, Cahill MT, Wong JS. Systemic considerations in the management of diabetic retinopathy. Am J Ophthalmol. 2001;132:760–76.PubMedCrossRef Aiello LP, Cahill MT, Wong JS. Systemic considerations in the management of diabetic retinopathy. Am J Ophthalmol. 2001;132:760–76.PubMedCrossRef
42.
Zurück zum Zitat Yadav S, Cotlarciuc I, Munroe PB, et al. Genome-wide analysis of blood pressure variability and ischemic stroke. Stroke. 2013;44:2703–9.PubMedCrossRef Yadav S, Cotlarciuc I, Munroe PB, et al. Genome-wide analysis of blood pressure variability and ischemic stroke. Stroke. 2013;44:2703–9.PubMedCrossRef
43.
Zurück zum Zitat Dichgans M, Malik R, Konig IR, et al. Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants. Stroke. 2014;45:24–36.PubMedCrossRef Dichgans M, Malik R, Konig IR, et al. Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants. Stroke. 2014;45:24–36.PubMedCrossRef
44.
Zurück zum Zitat Andreassen OA, McEvoy LK, Thompson WK, et al. Identifying common genetic variants in blood pressure due to polygenic pleiotropy with associated phenotypes. Hypertension. 2014;63:819–26. Andreassen OA, McEvoy LK, Thompson WK, et al. Identifying common genetic variants in blood pressure due to polygenic pleiotropy with associated phenotypes. Hypertension. 2014;63:819–26.
45.
Zurück zum Zitat Tang H, Wei P, Duell EJ, et al. Genes-environment interactions in obesity- and diabetes-associated pancreatic cancer: a GWAS data analysis. Cancer Epidemiol Biomarkers Prev. 2014;23:98–106.PubMedCrossRef Tang H, Wei P, Duell EJ, et al. Genes-environment interactions in obesity- and diabetes-associated pancreatic cancer: a GWAS data analysis. Cancer Epidemiol Biomarkers Prev. 2014;23:98–106.PubMedCrossRef
46.
Zurück zum Zitat Wang Z, Liu X, Yang BZ, Gelernter J. The role and challenges of exome sequencing in studies of human diseases. Front Genet. 2013;4:160.PubMedCentralPubMed Wang Z, Liu X, Yang BZ, Gelernter J. The role and challenges of exome sequencing in studies of human diseases. Front Genet. 2013;4:160.PubMedCentralPubMed
47.
Zurück zum Zitat Seddon JM, Yu Y, Miller EC, et al. Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration. Nat Genet. 2013;45:1366–70.PubMedCentralPubMedCrossRef Seddon JM, Yu Y, Miller EC, et al. Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration. Nat Genet. 2013;45:1366–70.PubMedCentralPubMedCrossRef
48.
Zurück zum Zitat Schmidt-Erfurth U, Lang GE, Holz FG, et al. Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: the RESTORE Extension study. Ophthalmology. 2014;121:1045–53. Schmidt-Erfurth U, Lang GE, Holz FG, et al. Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: the RESTORE Extension study. Ophthalmology. 2014;121:1045–53.
49.
Zurück zum Zitat Brown DM, Nguyen QD, Marcus DM, et al. Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE. Ophthalmology. 2013;120:2013–22.PubMedCrossRef Brown DM, Nguyen QD, Marcus DM, et al. Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE. Ophthalmology. 2013;120:2013–22.PubMedCrossRef
50.
Zurück zum Zitat Nicholson BP, Schachat AP. A review of clinical trials of anti-VEGF agents for diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2010;248:915–30.PubMedCrossRef Nicholson BP, Schachat AP. A review of clinical trials of anti-VEGF agents for diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2010;248:915–30.PubMedCrossRef
51.
Zurück zum Zitat Qi HP, Bi S, Wei SQ, Cui H, Zhao JB. Intravitreal vs subtenon triamcinolone acetonide injection for diabetic macular edema: a systematic review and meta-analysis. Curr Eye Res. 2012;37:1136–47.PubMedCrossRef Qi HP, Bi S, Wei SQ, Cui H, Zhao JB. Intravitreal vs subtenon triamcinolone acetonide injection for diabetic macular edema: a systematic review and meta-analysis. Curr Eye Res. 2012;37:1136–47.PubMedCrossRef
52.
Zurück zum Zitat El-Shazly SF, El-Bradey MH. Tameesh MK. Vascular endothelial growth factor gene polymorphism prevalence in patients with diabetic macular edema and its correlation with anti-VEGF treatment outcomes. Clin Exp Ophthalmol. 2014;42:369–78. El-Shazly SF, El-Bradey MH. Tameesh MK. Vascular endothelial growth factor gene polymorphism prevalence in patients with diabetic macular edema and its correlation with anti-VEGF treatment outcomes. Clin Exp Ophthalmol. 2014;42:369–78.
Metadaten
Titel
Genetics of Diabetic Retinopathy
verfasst von
Heeyoon Cho
Lucia Sobrin
Publikationsdatum
01.08.2014
Verlag
Springer US
Erschienen in
Current Diabetes Reports / Ausgabe 8/2014
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-014-0515-z

Weitere Artikel der Ausgabe 8/2014

Current Diabetes Reports 8/2014 Zur Ausgabe

Microvascular Complications—Nephropathy (B Roshan, Section Editor)

Resistant Hypertension in Diabetes Mellitus

Psychosocial Aspects (KK Hood, Section Editor)

Goal Setting: An Integral Component of Effective Diabetes Care

Microvascular Complications—Retinopathy (JK Sun, Section Editor)

Ultra Widefield Fundus Imaging for Diabetic Retinopathy

Microvascular Complications—Nephropathy (B Roshan, Section Editor)

Novel Urinary Biomarkers in Early Diabetic Kidney Disease

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.